Ultragenyx Pharmaceutical Chief Accounting Officer Theodore Alan Huizenga sold 1,283 shares at $13.57 per share on September 15, 2026. For investors, the transaction represented about 1.9% of his prior holding, while his disclosed ownership after the sale stood at 67,863 shares.

Key Highlights

  • The transaction was recorded on 15 September 2026.
  • Theodore Alan Huizenga is Ultragenyx Pharmaceutical’s Chief Accounting Officer.
  • The filing reports SEC transaction code S.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) Chief Accounting Officer Theodore Alan Huizenga sold 1,283 shares at $13.57 per share. The transaction was completed on 15 September 2026.

Ultragenyx Insider Transaction Details

Huizenga serves as Ultragenyx Pharmaceutical’s Chief Accounting Officer. The transaction was classified under SEC code S. The sale involved shares of Ultragenyx Pharmaceutical. Huizenga’s position following the transaction is addressed separately below.

Sale Represents 1.9% of Prior Holding

The transaction represented about 1.9% of Huizenga’s prior Ultragenyx Pharmaceutical shareholding. His ownership after the transaction stood at 67,863 shares. The 1.9% figure compares the sale with his holdings before the transaction.